Clinical Trial Update: Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for chidamide in patients with relapse or refractory diffuse large B-cell lymphoma and follicular lymphoma is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Experimental | Phase 2 | Status: UNKNOWN